TMCO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.77270000012442E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.61586999999352E-05 |
Normal-vs-Stage2 |
1.749600E-01 |
Normal-vs-Stage3 |
1.14520000005225E-06 |
Normal-vs-Stage4 |
1.56120000005533E-06 |
Stage1-vs-Stage2 |
3.565200E-01 |
Stage1-vs-Stage3 |
1.334620E-01 |
Stage1-vs-Stage4 |
2.277400E-01 |
Stage2-vs-Stage3 |
1.004240E-01 |
Stage2-vs-Stage4 |
1.191630E-01 |
Stage3-vs-Stage4 |
8.606600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.28309999975529E-07 |
Normal-vs-AfricanAmerican |
1.78419999996571E-07 |
Normal-vs-Asian |
2.964400E-02 |
Caucasian-vs-AfricanAmerican |
6.820000E-02 |
Caucasian-vs-Asian |
7.571600E-01 |
AfricanAmerican-vs-Asian |
7.652200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.54629999915556E-08 |
Normal-vs-Female |
1.323760E-03 |
Male-vs-Female |
3.210300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.83619999996709E-06 |
Normal-vs-Age(41-60Yrs) |
2.04940000003706E-06 |
Normal-vs-Age(61-80Yrs) |
1.07309999997085E-06 |
Normal-vs-Age(81-100Yrs) |
7.427200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.838220E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.328210E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.212400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.426800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.748800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.809000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.663600E-02 |
Normal-vs-Grade 2 |
1.336150E-03 |
Normal-vs-Grade 3 |
1.57600000050273E-07 |
Normal-vs-Grade 4 |
2.09740003143111E-09 |
Grade 1-vs-Grade 2 |
7.435200E-01 |
Grade 1-vs-Grade 3 |
5.880400E-01 |
Grade 1-vs-Grade 4 |
1.193590E-01 |
Grade 2-vs-Grade 3 |
4.413800E-02 |
Grade 2-vs-Grade 4 |
5.236300E-04 |
Grade 3-vs-Grade 4 |
7.635800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.904200E-02 |
Normal-vs-ccB subtype |
1.10150000232068E-09 |
ccA subtype-vs-ccB subtype |
4.14579999996612E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.99609999999418E-05 |
Normal-vs-N1 |
3.890400E-01 |
N0-vs-N1 |
6.915800E-01 |
|
|